Table: Cyfuse Biomedical - Q1 parent results

Cyfuse Biomedical KK

15/05/2024 07:30

May 15 (Reuters)- 
             Cyfuse Biomedical K.K. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to  
                Mar 31, 2024        Mar 31, 2023      Dec 31, 2024  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            10 mln               7 mln            605 mln    
                 (+52.0 pct)                          (+891.4 pct)  
  Operating     loss 229 mln        loss 172 mln      loss 797 mln  
  Recurring     loss 223 mln        loss 167 mln      loss 724 mln  
  Net           loss 224 mln        loss 168 mln      loss 727 mln  
  EPS          loss 28.38 yen      loss 21.56 yen    loss 92.16 yen 
  Ann Div                                NIL               NIL      
  -Q2 div                                NIL               NIL      
  -Q4 div                                NIL               NIL      
  
  NOTE - Cyfuse Biomedical K.K.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4892.T